Stengone Carmine N. bought CTNM
February 11, 2026 · Form 4 insider transaction
Stengone Carmine N. bought 400 shares of Contineum Therapeutics, Inc. at $1.26 per share, a transaction worth $504.00. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
400
Price
$1.26
Total value
$504.00
InsiderStengone Carmine N.
Role—
SecurityClass A Common Stock
Transaction codeM: Option exercise
Transaction dateFebruary 11, 2026
Filing dateFebruary 13, 2026
Shares owned after15,354
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.; Includes 1,246 shares purchased through Issuer's Employee Stock Purchase Plan on November 15, 2024 and 2,096 shares purchased through Issuer's Employee Stock Purchase Plan on May 15, 2025.